AVDL
Avadel Pharmaceuticals plc · Healthcare · Drug Manufacturers - Specialty & Generic
Last
$21.65
+$0.02 (+0.09%) 4:00 PM ET
After hours $21.33 −$0.32 (−1.50%) 6:39 PM ET
Prev close $21.63
Open $21.67
Day high $21.76
Day low $21.63
Volume 13,345,880
Avg vol 2,595,952
FY Revenue
$248.52M
EPS
0.00
Gross Margin
94.91%
Sector
Healthcare
AI report sections
AVDL
Avadel Pharmaceuticals plc
Avadel Pharmaceuticals shows strong medium- to long-horizon price performance and constructive technical positioning near the upper end of its 52-week range. Fundamentals indicate rapid revenue and earnings improvement with positive operating cash flow and a healthy current ratio, offset by very slim operating profitability and slightly negative net margin. Short interest and recent news flow appear moderate and largely neutral, while ongoing merger-related legal reviews introduce transaction and regulatory process uncertainty.
AI summarized at 3:33 AM ET, 2025-12-20
AI summary scores
INTRADAY: 63 SWING: 76 LONG: 79
Volume vs average
Intraday (cumulative)
−100% (Below avg)
Vol/Avg: 0.00×
RSI
55.38 (Neutral)
Neutral (40–60)
MACD momentum
Intraday
+0.00 (Neutral)
MACD: 0.00 Signal: 0.00
Short-Term
+0.02 (Strong)
MACD: 0.00 Signal: -0.02
Long-Term
+0.04 (Strong)
MACD: -0.19 Signal: -0.23
Intraday trend score 62.20

Latest news

AVDL No articles found.
News is temporarily unavailable.
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal